tiprankstipranks
CG Oncology, Inc. (CGON)
NASDAQ:CGON
US Market

CG Oncology, Inc. (CGON) Financial Statements

Compare
130 Followers

CG Oncology, Inc. Financial Overview

CG Oncology, Inc.'s market cap is currently $2.15B. The company's EPS TTM is $-1.276; its P/E ratio is ―; CG Oncology, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 204.00K$ 191.00K$ 10.36M
Gross Profit$ 204.00K$ 176.00K$ 10.35M
Operating Income$ -55.45M$ -35.25M$ -12.61M
EBITDA$ -55.43M$ -35.23M$ -12.38M
Net Income$ -48.61M$ -35.44M$ -12.84M
Balance Sheet
Cash & Short-Term Investments$ 187.67M$ 143.48M$ 53.61M
Total Assets$ 199.30M$ 147.75M$ 58.69M
Total Debt$ 461.00K$ 16.30M$ 15.48M
Net Debt$ -7.80M$ -71.85M$ -38.13M
Total Liabilities$ 14.51M$ 22.57M$ 18.44M
Stockholders' Equity$ 184.79M$ 125.18M$ 40.25M
Cash Flow
Free Cash Flow$ -45.68M$ -29.82M$ -13.75M
Operating Cash Flow$ -45.68M$ -29.80M$ -13.65M
Investing Cash Flow$ -121.19M$ -55.35M$ -97.00K
Financing Cash Flow$ 87.00M$ 119.69M$ 15.45M
Currency in USD

CG Oncology, Inc. Earnings and Revenue History

CG Oncology, Inc. Debt to Assets

CG Oncology, Inc. Cash Flow

CG Oncology, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis